The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment

Abstract Introduction An Alzheimer's disease (AD) biomarker adjusted for age‐related brain changes should improve specificity for AD‐related pathological burden. Methods We calculated a brain‐age‐adjusted “personalized AD cortical thickness index” (pADi) in mild cognitive impairment patients fr...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Annie M. Racine, Michael Brickhouse, David A. Wolk, Bradford C. Dickerson, Alzheimer's Disease Neuroimaging Initiative
Natura: Artigo
Lingua:Inglês
Pubblicazione: Wiley 2018-01-01
Serie:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Soggetti:
AD index
AD signature
Alzheimer's disease
Cortical thickness
Mild cognitive impairment
Accesso online:https://doi.org/10.1016/j.dadm.2018.02.007
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi